Bell Investment Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-205
Closed -$402 1858
2026
Q1
$402 Buy
+205
New +$481 ﹤0.01% 1814
2021
Q4
$0 Sell
15
-17
-53% -$684 ﹤0.01% 1844
2021
Q3
$1K Buy
+32
New +$1.16K ﹤0.01% 1387

Other funds holding GDRX

Bell Investment Advisors's GDRX Position: Q2 2026 in Review

Bell Investment Advisors sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 205 shares — an estimated $402 sold.

Bell Investment Advisors first reported a position in GDRX in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Bell Investment Advisors reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Bell Investment Advisors sold 205 GoodRx Holdings shares in Q2 2026, an estimated $402.
  • Bell Investment Advisors first reported a position in GoodRx Holdings in Q3 2021 and held it in 3 quarters.
  • Bell Investment Advisors's GoodRx Holdings position peaked at $1K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.